The Kitov Pharma Ltd (KTOV) shares are trading at lower $0.79.
To add more color to this target, the company’s high over the last year is $1.44 and the low is $0.22. Over the last 52 weeks, KTOV is down -44.94% while the S&P 500 is down -0.33%. The catalyst for this interesting swing was the company’s recent earnings report.
A Notable Earnings Report
Find out when KTOV reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.
Of course, we must look beyond the financials and question how well those numbers represent the sustainable earnings power of the business. Investors need to know how sustainable this current run. KTOV has a short ratio of 0.20 and outstanding shares of 157.25M.
KTOV has seen increased volume after this news and investors are putting their support behind the value proposition. Furthermore, 10-day volume stands at 21.51 million and more growth is possible in the weeks ahead. Traders will also note the company’s earnings per share came in at -0.30. Kitov Pharma Ltd KTOV also noted assets of $14.68 million at the end of the last quarter. Investors should also keep an eye on sector updates as KTOV has historically followed its peers on positive news.
All told, Kitov Pharma Ltd KTOV has strung together solid data and demonstrated underlying fundamentals. At its current valuation, KTOV represents an interesting risk/reward case. Traders should stay tuned to see if this recent report will push the stock to test recent resistance levels.
Kitov Pharma Ltd KTOV is now commanding a market cap of 124.67M and a float of 35.33M. KTOV is increasing its credibility in this sector and that could lead to more upside down the line. Sign-up for continuing coverage on shares of KTOV stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!
Disclosure: we hold no position in KTOV, either long or short, and we have not been compensated for this article.